FY2027 Earnings Forecast for Revvity Issued By KeyCorp

Revvity Inc. (NYSE:RVTY) – Equities research analysts at KeyCorp issued their FY2027 earnings per share (EPS) estimates for Revvity in a report released on Tuesday, November 3rd. KeyCorp analyst P. Knight forecasts that the company will post earnings of $5.96 per share for the year. KeyCorp has an “Overweight” rating and a $165.00 price objective on the stock. The consensus estimate for Revvity’s current full-year earnings is $5.42 per share.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.08. Revvity had a return on equity of 8.64% and a net margin of 8.61%. The firm had revenue of $728.90 million for the quarter, compared to analyst estimates of $694.73 million. During the same quarter in the prior year, the company earned $1.18 earnings per share. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year.

A number of other equities research analysts have also recently weighed in on RVTY. Barclays increased their price target on Revvity from $160.00 to $175.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 4th. TD Cowen lifted their target price on shares of Revvity from $175.00 to $185.00 and gave the stock a “buy” rating in a report on Wednesday, November 4th. William Blair began coverage on shares of Revvity in a report on Monday, October 5th. They set an “outperform” rating for the company. Cfra upgraded shares of Revvity from a “hold” rating to a “buy” rating in a research note on Wednesday, November 4th. Finally, Weiss Ratings raised shares of Revvity from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday. Six analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. Based on data from MarketBeat.com, Revvity has a consensus rating of “Hold” and a consensus price target of $133.86.

Revvity Stock Performance

Shares of NYSE RVTY opened at $157.11 on Friday. The company has a current ratio of 2.65, a quick ratio of 2.10 and a debt-to-equity ratio of 0.36. Revvity has a 12 month low of $81.22 and a 12 month high of $171.74. The stock has a 50 day moving average of $150.01 and a 200-day moving average of $114.10. The company has a market capitalization of $17.54 billion, a P/E ratio of 69.52, a P/E/G ratio of 2.77 and a beta of 1.08.

Hedge Funds Weigh In On Revvity

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Jupiter Topco LLC bought a new stake in shares of Revvity during the 2nd quarter worth approximately $961,017,000. BlackRock Inc. bought a new position in Revvity in the second quarter valued at approximately $852,070,000. EdgePoint Investment Group Inc. increased its stake in Revvity by 3.1% in the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock valued at $771,044,000 after acquiring an additional 265,204 shares during the last quarter. Janus Henderson Group PLC raised its position in Revvity by 2.3% during the first quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock valued at $731,386,000 after purchasing an additional 186,956 shares in the last quarter. Finally, State Street Corp raised its position in Revvity by 0.6% during the third quarter. State Street Corp now owns 4,370,897 shares of the company’s stock valued at $668,266,000 after purchasing an additional 28,158 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Revvity

In related news, insider Maxwell Krakowiak sold 1,631 shares of the firm’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $144.53, for a total value of $235,728.43. Following the transaction, the insider owned 14,781 shares in the company, valued at approximately $2,136,297.93. This trade represents a 9.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Tajinder Vohra sold 7,330 shares of the firm’s stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the transaction, the insider owned 6,635 shares in the company, valued at $934,738.80. The trade was a 52.49% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 9,045 shares of company stock worth $1,281,439. 0.85% of the stock is currently owned by insiders.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Friday, January 22nd will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 22nd. Revvity’s dividend payout ratio is 12.39%.

Revvity Company Profile

Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company’s work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.